Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

UNKNOWN 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Hepatocellular 2Rare Malignant Neoplasm 1Myeloproliferative Disorders 1Melanoma 1Immunoglobulin Light-chain Amyloidosis 1Hereditary Sensory and Autonomic Neuropathies 1Hepatitis B 1Dysplastic Nevus Syndrome 1Complicated Adrenal Tumor Diseases 1Colorectal Adenocarcinoma 1Brain Neoplasms 1

Interventions

Surveys and Questionnaires 15Radiosurgery 14Magnetic Resonance Imaging 11Magnetic Resonance Spectroscopy 10Neuropsychological Tests 8Radiotherapy 7Radiation 4Blood Specimen Collection 4Patient Reported Outcome Measures 3sacituzumab govitecan 2Trastuzumab 2Surgical Procedures, Operative 2Quality of Life 2Physical Examination 2Phlebotomy 2Perfusion Magnetic Resonance Imaging 2Lead 2Lapatinib 2Interviews as Topic 2Immunotherapy 2Drug Therapy 2Data Collection 2Brain Mapping 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 2Aminolevulinic Acid 2trastuzumab deruxtecan 1pembrolizumab 1osimertinib 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Brain Neoplasms × Pharmaceutical Preparations × Clear all
NCT03338075 2017-11-09

FSRT Combined With TMZ for Large BMs: a PSM Study

ChineseAMS

Completed
72 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡